ImmoINTEL provides a more comprehensive report to guide selection of immunotherapy and other treatments to augment immune response.
ImmunoINTEL is a defined platform to provide more precise quantification and characterization of all tumor and immune populations within a tumor sample. With ImmunoINTEL physicians have significant and substantive data enabling them to more precisely prescribe and augment their immunotherapy treatment plan. ImmunoINTEL includes the ability to quantify IMR expression on tumor and the immune cells present in the tumor microenvironment; and characterize the functional status of immune cells within the tumor microenvironment as activated or suppressed.
Currently approved tests are IHC measurement of IMR expression. IHC alone does not fully inform on the complex immune response landscape.